169 related articles for article (PubMed ID: 10550829)
1. Drug-radiation interactions in tumor blood vessels.
Hallahan DE; Chen AY; Teng M; Cmelak AJ
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):71-7. PubMed ID: 10550829
[TBL] [Abstract][Full Text] [Related]
2. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
3. Potential role of vascular targeted therapy to combat against tumor.
Chen B; Jin H; Wu K
Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
[TBL] [Abstract][Full Text] [Related]
4. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy: creating a unique "window" of opportunity.
Lin MI; Sessa WC
Cancer Cell; 2004 Dec; 6(6):529-31. PubMed ID: 15607955
[TBL] [Abstract][Full Text] [Related]
6. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
7. Advancement of antiangiogenic and vascular disrupting agents combined with radiation.
Citrin D; Camphausen K
Cancer Treat Res; 2008; 139():153-71. PubMed ID: 18236716
[No Abstract] [Full Text] [Related]
8. Accumulation of P-selectin in the lumen of irradiated blood vessels.
Hallahan DE; Virudachalam S
Radiat Res; 1999 Jul; 152(1):6-13. PubMed ID: 10381836
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
ten Hagen TL; Seynhaeve AL; Eggermont AM
Immunol Rev; 2008 Apr; 222():299-315. PubMed ID: 18364010
[TBL] [Abstract][Full Text] [Related]
10. Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium.
Hallahan D; Kuchibhotla J; Wyble C
Cancer Res; 1996 Nov; 56(22):5150-5. PubMed ID: 8912850
[TBL] [Abstract][Full Text] [Related]
11. Vascular damaging agents.
Patterson DM; Rustin GJ
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
[TBL] [Abstract][Full Text] [Related]
12. Taking down tumors: vascular disrupting agents entering clinical trials.
O'Hanlon LH
J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
[No Abstract] [Full Text] [Related]
13. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
Horsman MR; Bohn AB; Busk M
Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
[TBL] [Abstract][Full Text] [Related]
14. Combination of vascular disrupting agents and ionizing radiation.
Clémenson C; Chargari C; Deutsch E
Crit Rev Oncol Hematol; 2013 May; 86(2):143-60. PubMed ID: 23177097
[TBL] [Abstract][Full Text] [Related]
15. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.
Kim DW; Huamani J; Fu A; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):38-46. PubMed ID: 16377414
[TBL] [Abstract][Full Text] [Related]
16. X-ray-induced P-selectin localization to the lumen of tumor blood vessels.
Hallahan DE; Staba-Hogan MJ; Virudachalam S; Kolchinsky A
Cancer Res; 1998 Nov; 58(22):5216-20. PubMed ID: 9823335
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and future directions for angiogenesis-based cancer therapies.
Scappaticci FA
J Clin Oncol; 2002 Sep; 20(18):3906-27. PubMed ID: 12228212
[TBL] [Abstract][Full Text] [Related]
18. Current development status of small-molecule vascular disrupting agents.
Chaplin DJ; Horsman MR; Siemann DW
Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
[TBL] [Abstract][Full Text] [Related]
19. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and radiotherapy for cancer treatment.
Kobayashi H; Lin PC
Histol Histopathol; 2006 Oct; 21(10):1125-34. PubMed ID: 16835835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
